Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-02-05 @ 6:51 PM
Study NCT ID:
NCT04020705
Status:
COMPLETED
Last Update Posted:
2019-07-16
First Post:
2019-04-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
Sponsor:
Istituto di Ricerca Neuroftalmologia S.r.l.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-22
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-19
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-12
First Submit QC Date:
None
Study First Post Date:
2019-07-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-15
Last Update Post Date:
2019-07-16
Last Update Post Date Type:
ACTUAL